← Eichor
Study identifier: NCT07469462 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms

Condition: Neural Inhibition · Anxiety · Depression  ·  Sponsor: University of Reading

PhaseNA
Planned participants44
Who can joinAll sexes, 18 Years to 41 Years
Healthy volunteersYes

About this study

This clinical trial investigates the effects of Vitamin B6 supplementation on neural inhibition using electroencephalography (EEG), in relation to depression and anxiety symptoms in participants from the general population with a relatively high level of symptoms at baseline. Researchers will compare a placebo group to high-dose Vitamin B6 to test the hypothesis that Vitamin B6 moves the excitation/inhibition balance towards inhibition.

This description comes directly from the study's public registry record.

Talk to the study team

Alex Cameron  ·  0118 378 6803  ·  a.cameron@pgr.reading.ac.uk

David T Field  ·  +44 1183785004  ·  d.t.field@reading.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Harry Pitt BuildingReading, England, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07469462